2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

200 views
July 9, 2024
0 Comments
Login to view comments. Click here to Login